Home » Topics » Regulatory

Regulatory
RSS

FDA approves Merck & Co.'s Zepatier for HCV infection

Jan. 29, 2016

Expanded FDA approvals for Opdivo + Yervoy and single-agent Opdivo in melanoma

Jan. 25, 2016

UCB's Briviact approved in E.U. as adjunctive treatment for partial-onset seizures

Jan. 22, 2016

FDA approves Neulasta to treat radiation sickness

Jan. 21, 2016

SK Chemicals' SKY Cellflu Quadrivalent approved in South Korea

Dec. 29, 2015

FDA approves AstraZeneca's Zurampic for hyperuricemia in gout

Dec. 23, 2015

FDA approves Uptravi for pulmonary arterial hypertension

Dec. 22, 2015

FDA approves Keytruda for first-line treatment of unresectable or metastatic melanoma

Dec. 21, 2015

FDA approves Otiprio for pediatric patients undergoing tympanostomy tube placement

Dec. 14, 2015

FDA approves Vistogard to treat overdose or severe toxicities due to 5-FU or capecitabine

Dec. 14, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...